119th Congress

H.R.8269

CLEAR LABELS Act Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act

Introduced·4/14/26

Prefiled

Introduced4/14/26

Chamber Passed

Final Passage

Complete

Introduced

H. R. 8269

Introduced in House · April 17, 2026

April 14, 2026

Mr. McCormick (for himself and Ms. DeLauro) introduced the following bill; which was referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

A BILL

To amend the Federal Food, Drug, and Cosmetic Act to require drug labeling to include original manufacturer and supply chain information.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act” or the “CLEAR LABELS Act”.

HR8269 U.S. House: CLEAR LABELS Act Consumer Labeling for…